🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

BRIEF-Knight Therapeutics And Jaguar Health Announce Strategic Partnership

Published 2018-09-24, 04:41 p/m
© Reuters.  BRIEF-Knight Therapeutics And Jaguar Health Announce Strategic Partnership
GUD
-

Sept 24 (Reuters) - Knight Therapeutics Inc GUD.TO :

* KNIGHT THERAPEUTICS AND JAGUAR HEALTH ANNOUNCE STRATEGIC PARTNERSHIP

* KNIGHT THERAPEUTICS INC - TO BE RESPONSIBLE FOR ALL REGULATORY AND COMMERCIAL ACTIVITIES FOR MYTESI AND RELATED PRODUCTS IN LICENSED TERRITORIES

* KNIGHT THERAPEUTICS - UPON ACHIEVEMENT OF REGULATORY, SALES MILESTONES IN AGREEMENT, JAGUAR TO RECEIVE PAYMENTS FROM CO OF UP TO $18.0 MILLION

* KNIGHT THERAPEUTICS - AGREEMENT GRANTS CO EXCLUSIVE RIGHT TO COMMERCIALIZE MYTESI AND RELATED PRODUCTS IN CANADA AND ISRAEL

* KNIGHT THERAPEUTICS INC - AGREEMENT GRANTS CO A RIGHT OF FIRST NEGOTIATION TO COMMERCIALIZE MYTESI & RELATED PRODUCTS IN SPECIFIED LATAM COUNTRIES

* KNIGHT THERAPEUTICS INC - JAGUAR IS ALSO PURSUING POSSIBLE FOLLOW-ON INDICATIONS FOR MYTESI IN CANCER THERAPY-RELATED DIARRHEA

* KNIGHT THERAPEUTICS - JAGUAR TO RECEIVE PAYMENTS FROM CO OF UP TO $18.0 MILLION THROUGHOUT INITIAL 15-YEAR TERM OF AGREEMENT

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.